Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS)

van Veelen, Ard; Abtahi, Shahab; Souverein, Patrick; Driessen, Johanna H. M.; Klungel, Olaf H.; Dingemans, Anne-Marie; van Geel, Robin; de Vries, Frank; Croes, Sander

doi:https://doi.org/10.1002/pds.5113-2

Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS)

DSpace/Manakin Repository

Characteristics and study eligibility of British lung cancer patients for clinical trials evaluating targeted therapies (TTS) or immune checkpoint inhibitors (ICIS)

van Veelen, Ard; Abtahi, Shahab; Souverein, Patrick; Driessen, Johanna H. M.; Klungel, Olaf H.; Dingemans, Anne-Marie; van Geel, Robin; de Vries, Frank; Croes, Sander

(2020) Pharmacoepidemiology and Drug Safety, volume 29, issue suppl. 3, pp.

(Abstract)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Keywords: Taverne

DOI: https://doi.org/10.1002/pds.5113-2

ISSN: 1053-8569

Publisher: John Wiley and Sons Ltd

See more statistics about this item